Search research articles
Contact Us
Filters
Showing results (21-30 of 100) with videos related to
Page
of 10
Sort By:
Cardiovascular Endocrinology
|
April 11, 2017
The inflammatory biomarker YKL-40 decreases stepwise after exercise stress test
Naja Dam Mygind, Anna Axelsson, Martin H Ruwald, et al.
Heart (British Cardiac Society)
|
December 15, 2015
Functional effects of losartan in hypertrophic cardiomyopathy-a randomised clinical trial
Anna Axelsson, Kasper Iversen, Niels Vejlstrup, et al.
Circulation
|
December 1, 2012
Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing
Morten K Jensen, Ole Havndrup, Michael Christiansen, et al.
International Journal of Cardiology
|
May 1, 2013
Exercise-induced changes in left ventricular filling pressure after myocardial infarction assessed with simultaneous right heart catheterization and Doppler echocardiography
Mads J Andersen, Mads Ersbøll, Finn Gustafsson, et al.
Circulation
|
August 16, 2015
Risk of Cardiomyopathy in Younger Persons With a Family History of Death from Cardiomyopathy: A Nationwide Family Study in a Cohort of 3.9 Million Persons
Mattis F Ranthe, Lisbeth Carstensen, Nina Øyen, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
March 26, 2014
Atrioventricular conduction after alcohol septal ablation for obstructive hypertrophic cardiomyopathy
Anna Axelsson, Kristina Weibring, Ole Havndrup, et al.
American Heart Journal
|
November 18, 2023
Angiotensin receptor blockers in patients with hypertrophic cardiomyopathy: A comparison of VANISH and INHERIT randomized trials
Tino Severinsen, Jens Jakob Thune, Helga Lillian Gudmundsdottir, et al.
The Lancet. Diabetes & Endocrinology
|
December 24, 2014
Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial
Anna Axelsson, Kasper Iversen, Niels Vejlstrup, et al.
International Journal of Cardiology
|
November 20, 2015
Left ventricular volume predicts exercise capacity in hypertrophic cardiomyopathy
Anna Axelsson, Kasper Iversen, Niels Vejlstrup, et al.
Neonatology
|
July 20, 2022
The Impact of Maternal Age on the Neonatal Electrocardiogram
Maria Munk Pærregaard, Joachim Hartmann, Ottilia Vøgg, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 100) with videos related to
Sort By:
Page
of 10
Cardiovascular Endocrinology
|
April 11, 2017
The inflammatory biomarker YKL-40 decreases stepwise after exercise stress test
Naja Dam Mygind, Anna Axelsson, Martin H Ruwald, et al.
Heart (British Cardiac Society)
|
December 15, 2015
Functional effects of losartan in hypertrophic cardiomyopathy-a randomised clinical trial
Anna Axelsson, Kasper Iversen, Niels Vejlstrup, et al.
Circulation
|
December 1, 2012
Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing
Morten K Jensen, Ole Havndrup, Michael Christiansen, et al.
International Journal of Cardiology
|
May 1, 2013
Exercise-induced changes in left ventricular filling pressure after myocardial infarction assessed with simultaneous right heart catheterization and Doppler echocardiography
Mads J Andersen, Mads Ersbøll, Finn Gustafsson, et al.
Circulation
|
August 16, 2015
Risk of Cardiomyopathy in Younger Persons With a Family History of Death from Cardiomyopathy: A Nationwide Family Study in a Cohort of 3.9 Million Persons
Mattis F Ranthe, Lisbeth Carstensen, Nina Øyen, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
March 26, 2014
Atrioventricular conduction after alcohol septal ablation for obstructive hypertrophic cardiomyopathy
Anna Axelsson, Kristina Weibring, Ole Havndrup, et al.
American Heart Journal
|
November 18, 2023
Angiotensin receptor blockers in patients with hypertrophic cardiomyopathy: A comparison of VANISH and INHERIT randomized trials
Tino Severinsen, Jens Jakob Thune, Helga Lillian Gudmundsdottir, et al.
The Lancet. Diabetes & Endocrinology
|
December 24, 2014
Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial
Anna Axelsson, Kasper Iversen, Niels Vejlstrup, et al.
International Journal of Cardiology
|
November 20, 2015
Left ventricular volume predicts exercise capacity in hypertrophic cardiomyopathy
Anna Axelsson, Kasper Iversen, Niels Vejlstrup, et al.
Neonatology
|
July 20, 2022
The Impact of Maternal Age on the Neonatal Electrocardiogram
Maria Munk Pærregaard, Joachim Hartmann, Ottilia Vøgg, et al.
Page
of 10